DGX
Quest Diagnostics IncorporatedNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$22.48B
P/E Ratio
22.41
EPS
$9.06
Beta
0.59
52W High
$212.58
52W Low
$162.47
50-Day MA
$194.80
200-Day MA
$189.20
Dividend Yield
1.60%
Profit Margin
9.08%
Forward P/E
18.98
PEG Ratio
1.57
About Quest Diagnostics Incorporated
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Fundamentals
| Revenue (TTM) | $11.28B |
| Gross Profit (TTM) | $3.75B |
| EBITDA | $2.23B |
| Operating Margin | 14.20% |
| Return on Equity | 14.50% |
| Return on Assets | 6.35% |
| Revenue/Share (TTM) | $101.83 |
| Book Value | $66.36 |
| Price-to-Book | 3.06 |
| Price-to-Sales (TTM) | 1.99 |
| EV/Revenue | 2.534 |
| EV/EBITDA | 12.85 |
| Quarterly Earnings Growth (YoY) | 15.50% |
| Quarterly Revenue Growth (YoY) | 9.20% |
| Shares Outstanding | $110.70M |
| Float | $110.09M |
| % Insiders | 0.43% |
| % Institutions | 97.96% |
Historical Volatility
HV 10-Day
25.13%
HV 20-Day
20.55%
HV 30-Day
19.64%
HV 60-Day
22.00%
HV Rank
29.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($223.44 target)
2
Strong Buy7
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026